Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2023-02-20
2023-02-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calibration and Validation of the Masimo Temperature Device in Febrile Patients
NCT05674344
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
NCT05787782
The Clinical Performance Validation of Electronic Thermometer and Infrared Thermometers
NCT06353490
Fever Tracking Study
NCT05475067
Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice
NCT02805322
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Subject
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo RAD-GT
Masimo RAD-GT
Non-contact infrared thermometry device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Masimo RAD-GT
Non-contact infrared thermometry device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects are able to read and communicate in English as well as understand the study and the risks involved.
Exclusion Criteria
* Subject has a known neurological and/or psychiatric disorder (e.g., schizophrenia, bipolar disorder, Multiple Sclerosis, Huntington's disease) that interferes with the subject's level of consciousness. \*
* Subject has any medical condition which in the judgment of the investigator and/or study staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.
(\* = Per study staff discretion)
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Masimo Corporation
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
Calibration and Validation of the Masimo Temperature Device in Febrile Patients
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP-1064
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.